Apellis Pharmaceuticals Cash from Financing (Quarterly) Analysis

Apellis Pharmaceuticals Inc (APLS)

42.41 +0.11 (+0.26%) USD | NASDAQ | May 09, 16:00

42.41 0.00 (0.00%) After-Hours: 19:11

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	108.21M
December 31, 2023	-3.913M
September 30, 2023	5.746M
June 30, 2023	1.56M
March 31, 2023	391.11M
December 31, 2022	-15.95M
September 30, 2022	9.636M
June 30, 2022	-4.735M
March 31, 2022	376.70M
December 31, 2021	383.96M
September 30, 2021	2.12M
June 30, 2021	4.526M
March 31, 2021	1.632M
December 31, 2020	6.317M

Date	Value
September 30, 2020	0.926M
June 30, 2020	281.67M
March 31, 2020	403.27M
December 31, 2019	0.209M
September 30, 2019	198.95M
June 30, 2019	40.96M
March 31, 2019	148.42M
December 31, 2018	0.1153M
September 30, 2018	-0.0384M
June 30, 2018	131.60M
March 31, 2018	0.2227M
December 31, 2017	178.04M
September 30, 2017	19.33M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-15.95M

Minimum

Dec 2022

403.27M

Maximum

Mar 2020

109.65M

Average

6.032M

Median

Cash from Financing (Quarterly) Benchmarks

Blueprint Medicines Corp	66.96M
Sarepta Therapeutics Inc	22.14M
Alnylam Pharmaceuticals Inc	28.91M
Ionis Pharmaceuticals Inc	23.57M
Madrigal Pharmaceuticals Inc	479.92M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-132.98M
Cash from Investing (Quarterly)	-0.293M
Free Cash Flow	-550.90M
Free Cash Flow Per Share (Quarterly)	-1.084
Free Cash Flow to Equity (Quarterly)	-133.35M
Free Cash Flow to Firm (Quarterly)	-129.60M
Free Cash Flow Yield	-10.74%